# Ultra Seal Corporation – FDA Inspection, Sep 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/c19adf9f-5907-48fb-b684-902b8d26346c
Source feed: FDA_Inspections

> FDA inspection 1218129 of Ultra Seal Corporation, September 20, 2023. Classification: Voluntary Action Indicated (VAI). 10 citations under 21 CFR part 211. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218129
- Company Name: Ultra Seal Corporation
- Inspection Date: 2023-09-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 10

## Related Documents

- [FDA Inspection 1338618 - 2026-09-03](https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/1c499379-feb6-4045-ae46-b2ca42a28530)
- [FDA Inspection 1263334 - 2025-03-04](https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/f4a128f6-cbf0-48bf-8268-7dbc27f4e6bb)
- FDA Inspection 1229281 - 2024-05-02
- FDA Inspection 1228761 - 2024-02-05
- [FDA Inspection 1157142 - 2021-11-19](https://www.keypedia.com/records/fda_inspections/ultra-seal-corporation/646b6b1b-8fb2-4804-90b0-421383f1a299)

## Related Officers

- [Ruben C. Quintana](https://www.keypedia.com/people/ruben-c-quintana/fbf0f0ef-eb51-4a06-a4b9-f7856fa06c58)
- [FDA Associated Person](https://www.keypedia.com/people/syeda-n-mahazabin/54af6f8a-6d41-4399-b58e-a2d88fd2d7bf)
- [Issuing Officer](https://www.keypedia.com/people/tanya-r-syffrard/a78a42b3-6cef-46d9-9698-ec6082956477)

Company: https://www.keypedia.com/companies/ultra-seal-corporation/cf5b79d4-f6e6-4417-82f6-2ff3c6160a3c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
